Category

Daily Briefs

Daily Brief Energy/Materials: Exxon Mobil, China Bluechemical Ltd H, Phillips 66, Lyondellbasell Indu Cl A, NOV , Olin Corp, Chevron Corp, TotalEnergies , Crown Holdings, Kumba Iron Ore and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Exxon Mobil Corporation: The Pioneer Expansion & The Expansion of ExxonMobil’s Guyana Operations! – Major Drivers
  • China Bluechemical Ltd (3983.HK) – Fertiliser Pricing on the Up
  • Phillips 66: Potential For Expanded Flexibility With Trans Mountain Pipeline & Other Major Developments
  • LyondellBasell Industries: A Tale Of Improved Seasonal Demand and Customers’ Downtime!
  • NOV Inc.: Strong International Activity in Production and Midstream Business! – Major Drivers
  • Olin Corporation: A Story Of A Decent Economic Recovery and Demand Uptick! – Major Drivers
  • Chevron Corporation: Improving Productivity in the Permian Basin & 5 Pivotal Growth Drivers
  • TotalEnergies SE: Can They Capitalize On The LNG Market Opportunities in Asia & The US? – Major Drivers
  • Crown Holdings Inc.: Will The Management Focus on Value over Volume Bear Fruit? – Major Drivers
  • Kumba Iron Ore (KIO SJ): Net Cash Iron Ore Player With High ROCE


Exxon Mobil Corporation: The Pioneer Expansion & The Expansion of ExxonMobil’s Guyana Operations! – Major Drivers

By Baptista Research

  • ExxonMobil’s latest performance paints a promising picture, powered by strategic decisions, cost-saving measures, and a focus on long-term growth avenues.
  • In Q1 2024, ExxonMobil delivered $8.2 billion in earnings and $14.7 billion in cash flow, demonstrating ongoing efforts to enhance the company’s earnings power.
  • The company made big strides in cost savings, achieving $10.1 billion in Q1 compared to 2019, on track to reach their goal of $15 billion in savings by 2027.

China Bluechemical Ltd (3983.HK) – Fertiliser Pricing on the Up

By Rikki Malik

  • A play on higher food and energy prices going forward
  • Natural Gas moving up from multi-year lows will support fertiliser prices going forward
  • A Low valuation with a solid balance sheet lowers the risk

Phillips 66: Potential For Expanded Flexibility With Trans Mountain Pipeline & Other Major Developments

By Baptista Research

  • Phillips 66 reported its first-quarter earnings for fiscal 2024, emphasizing progress in strategic areas, despite some obstacles encountered during the quarter.
  • Mark Lashier, President and CEO, noted strong crude utilization rates during the quarter.
  • However, maintenance work limited the company’s ability to produce higher-value products, impacting the results.

LyondellBasell Industries: A Tale Of Improved Seasonal Demand and Customers’ Downtime!

By Baptista Research

  • The latest LyondellBasell earnings showcased several key trends and indicators that provide a comprehensive understanding of the company’s performance and future prospects.
  • On the positive side, LyondellBasell has made promising strides in improving safety metrics for its workers, leading to an impressive rate of just one injury per two million hours worked.
  • The operational excellence shown by this metric, as well as continued enhancements to LyondellBasell’s core business, has the potential to lead to consistent long-term growth.

NOV Inc.: Strong International Activity in Production and Midstream Business! – Major Drivers

By Baptista Research

  • NOV Inc.’s Q1 2024 financial results showed that revenues reached $2.16 billion, a 10% increase compared to Q1 2023, despite a decline in earnings per share from the previous year.
  • NOV reported a net income of $119 million or $0.30 per fully diluted share.
  • The reduced earnings per share were attributed to a higher effective tax rate and reduced income from the company’s joint venture.

Olin Corporation: A Story Of A Decent Economic Recovery and Demand Uptick! – Major Drivers

By Baptista Research

  • Olin Corporation’s Q1 2024 earnings indicated a positive long-term outlook for the company, though there are some elements that investors should monitor.
  • The company is currently demonstrating an investment-grade balance sheet alongside strong performance across its portfolio.
  • CEO Kenneth Lane emphasized his commitment to Olin’s operating model and value-focused commercial approach.

Chevron Corporation: Improving Productivity in the Permian Basin & 5 Pivotal Growth Drivers

By Baptista Research

  • Chevron Corporation recorded a strong first quarter of 2024, delivering its ninth successive quarter with adjusted earnings exceeding $5 billion and a return of capital employed (ROCE) above 12%.
  • The company also posted a more than 10% growth in production compared to the same quarter last year.
  • Chevron returned $6 billion in cash to shareholders in Q1 2024, marking its eighth consecutive quarter of returning over $5 billion.

TotalEnergies SE: Can They Capitalize On The LNG Market Opportunities in Asia & The US? – Major Drivers

By Baptista Research

  • TotalEnergies, in its Q1 2024, demonstrated firm progress in implementing its two-pillar strategy.
  • First, oil and gas production, most notably in Liquid Natural Gas (LNG), aims to responsibly address rising demand through ongoing development.
  • Second, investments in integrated power for the future hold the promise of achieving net cash positive status by 2028.

Crown Holdings Inc.: Will The Management Focus on Value over Volume Bear Fruit? – Major Drivers

By Baptista Research

  • Crown Holdings, known for its metal packaging technology and serving a wide array of sectors, including beverage packaging, food, personal care and household products, provided a robust first quarter performance of 2024 that showcased several positives as well as negatives for the company.
  • As per the latest earnings call transcript, the company announced earnings per diluted share of $0.56, a decrease from the prior year quarter when it was $0.85.
  • The adjusted diluted earnings per share were $1.02, lower than the $1.20 in the last year’s quarter.

Kumba Iron Ore (KIO SJ): Net Cash Iron Ore Player With High ROCE

By Sameer Taneja

  • Kumba Iron Ore (KIO SJ) is a net cash iron ore pure play on high-grade lump iron ore with a high ROCE of>30%. 
  • The stock trades at 6.4x PE/3.8x EV-EBITDA FY24e and a >9% dividend yield, assuming it meets its base dividend commitment of 15.9 bn ZAR. 
  • The key risks are the finite mine life of 15 years, which the company will look to extend with capital commitment, and country risk premia as currency depreciation eats returns.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Alps Logistics, Nippon Yusen Kk, HD Hyundai Marine Solution , Mitsubishi Heavy Industries, Innospace, Qantm Intellectual Property, Roper Technologies, Mastech Digital , Jetblue Airways and more

By | Daily Briefs, Industrials

In today’s briefing:

  • KKR Deal for Alps Logistics (9055) Appears Imminent
  • Nippon Yusen (9101) – Another Big Buyback Announced, But Details Matter
  • HD Hyundai Marine Solution (443060 KS): Nearing KOSPI200 Index Inclusion in June
  • Mitsubishi Heavy (7011) | Flying High
  • Innospace IPO Preview
  • Qantm IP (QIP AU): IPH Enters the Fray with a Competing Offer
  • QANTM (QIP AU): IPH Wades In As Adamantem Tarries
  • Roper Technologies Inc.: Transition to Cloud and SaaS-based Offerings! – Major Drivers
  • MHH: Mastech Sees Demand Improvement as Customers Loosen Their Purse Strings
  • Jetblue Airways Corp (JBLU) – Wednesday, Feb 7, 2024


KKR Deal for Alps Logistics (9055) Appears Imminent

By Travis Lundy

  • There was a news article I missed in late February saying Alps Alpine (6770 JP), parent of Alps Logistics (9055 JP) was in the process of selling the logistics unit.
  • A deal made sense for a strategic given the upcoming “2024 Problem”. Pre-close, headlines blared, the stock popped 12%, now we’re at double the end-February price.
  • Late in the evening,Alps Logistics said it had received a bid from Logisteed but nothing had been decided. This morning we have a few more details, but nothing concrete

Nippon Yusen (9101) – Another Big Buyback Announced, But Details Matter

By Travis Lundy

  • Last May, Nippon Yusen Kk (9101 JP) announced buybacks of ¥200bn over 2 years. In August, they changed it to say  ¥200bn in the next nine months.
  • That helped support the stock through early March. It was big, and a decent percentage of ADV. Today, they announced earnings and guidance and another ¥100bn buyback through April 2025.
  • Earnings were OK. Guidance is a little low vs the Street. The stock popped 5% from where it was trading. Lower impact vs 2023. More cross-holder overhang consideration. 

HD Hyundai Marine Solution (443060 KS): Nearing KOSPI200 Index Inclusion in June

By Brian Freitas


Mitsubishi Heavy (7011) | Flying High

By Mark Chadwick

  • MHI’s stock fell 7% following the announcement of results. Guidance for FY3/25 missed analyst expectations
  • Even so, MHI remains a key beneficiary of the global shift to clean energy and national policies aimed at bolstering national security 
  • We remain bullish. The stock has performed well this year and but 13x EV/EBIT seems reasonable given the structural drivers

Innospace IPO Preview

By Douglas Kim

  • Innospace is getting ready to complete its IPO in June 2024. According to bankers’ valuation, the implied market cap of Innospace is from 347 billion won to 434 billion won.
  • Innospace engages in the satellite launch vehicle production and launch service business.
  • The company estimates its sales to increase from 0.2 billion won in 2023 to 2.0 billion won in 2024, 47.8 billion won in 2025, and 97.2 billion won in 2026.

Qantm IP (QIP AU): IPH Enters the Fray with a Competing Offer

By Arun George

  • Qantm Intellectual Property (QIP AU)‘s non-binding proposal from IPH Ltd (IPH AU) is at A$0.11 cash + 0.291 IPH shares per QIP share, a 4.5% premium to Adamantem’s A$1.817 offer.
  • Since announcing the Adamantem non-binding proposal on 14 March, the IPH offer has been 4.3% higher than the Adamantem offer on average. 
  • The IPH proposal also requires approval from the ACCC and NZCC. The presence of two bidders increases the probability of a binding proposal (with a bump). 

QANTM (QIP AU): IPH Wades In As Adamantem Tarries

By David Blennerhassett

  • It always seemed like a question of when, not if, IPH (IPH AU) would make an Offer for QANTM (QIP AU). IPH previously approached QANTM in 2018, but was spurned.
  • Capitalising on ongoing extensions to Adamantem’s exclusivity, as it relates to its all-cash A$1.817/share Offer by way of a Scheme, IPH has now tabled an all-scrip, plus A$0.11/share dividend NBIO.
  • IPH’s implied Scheme value of A$1.90/share is a premium to Adamantem’s proposal. The catch: apart from terms being indicative, IPH’s Offer requires ACCC and NZCC clearance.

Roper Technologies Inc.: Transition to Cloud and SaaS-based Offerings! – Major Drivers

By Baptista Research

  • Roper Technologies had a robust start to the year, with double-digit growth in revenue, EBITDA, adjusted DEPS, and free cash flow noted for Q1, which has spurred an increased full-year outlook.
  • The Q1 report highlighted the completion of another milestone for the company – the acquisition of Procare Solutions, a provider of software and integrated payments for the early childhood education market.
  • The total revenue and organic revenue increased by 14% and 8% respectively while EBITDA saw a 16% growth, with EBITDA margin expanding by 60 basis points to 40.2%.

MHH: Mastech Sees Demand Improvement as Customers Loosen Their Purse Strings

By Zacks Small Cap Research

  • Mastech Digital, based outside Pittsburgh, PA is an IT staffing business with a data and analytics, consulting, and project management service serving blue-chip customers in the US. Both businesses have been affected by the rapid decline in the economy and IT hiring as customers pull back.
  • The company trades well below its peers and we expect stock price appreciation when it returns to growth aided by stock buybacks.
  • It also plans to grow through acquisition.

Jetblue Airways Corp (JBLU) – Wednesday, Feb 7, 2024

By Value Investors Club

  • JetBlue Airways Corporation (JBLU) identified as an attractive short opportunity due to unsustainable competitive and financial position
  • Struggling as sub-scale industry participant with shrinking margins, issues with GTF engines, and tough upcoming comps
  • Predicted restructuring within next 2-4 years as JBLU faces challenges in overcoming fundamental issues and high debt levels

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: China Traditional Chinese Medicine, WuXi AppTec, Dr. Reddy’s Laboratories, Oryzon Genomics, Abbvie Inc, X4 Pharmaceuticals , Elanco Animal Health , HCA Healthcare, Inc. and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • China Traditional Chinese Medicine (570 HK): Evaluating Deal-Break Risks
  • WuXi AppTec (2359.HK/603259.CH) – The Pain of 2024 Has Just Begun
  • Dr. Reddy’s Laboratories (DRRD IN): Q4 Result- Sequentially Weak Quarter; Time to Book Profit
  • Oryzon Genomics – Doubling down on clinical activity in 2024
  • AbbVie Inc.: Acquisition of Landos Biopharma to Enhance Autoimmune Disease Treatments & Other Major Developments
  • XFOR: Data from Phase 2 CN Trial Expected in June 2024
  • Elanco Animal Hlth Inc (ELAN) – Wednesday, Feb 7, 2024
  • HCA Healthcare: How Long Is The Continued Strength In Demand for Healthcare Services Expected To Last? – Major Drivers


China Traditional Chinese Medicine (570 HK): Evaluating Deal-Break Risks

By Arun George

  • On 21 February, China Traditional Chinese Medicine (570 HK) announced a privatisation offer from the Sinopharm-led consortium at HK$4.60 per share, a 47.4% premium to the undisturbed price.
  • The wide gross spread (7.0%) reflects risks around the re-rating of peers, the slow pace of satisfying the pre-condition, the completion timetable and Ping An’s blocking stake. 
  • The key risk is the deal close timing due to the slow pace of regulatory approvals, which increases the chance that the vote will held after the August interim.   

WuXi AppTec (2359.HK/603259.CH) – The Pain of 2024 Has Just Begun

By Xinyao (Criss) Wang

  • The growth of TIDES business slowed down, and revenue decreased QoQ despite increasing production capacity.As the main growth point of WuXi AppTec’s future performance, this is not a good signal.
  • Due to BIOSECURE Act, US companies have been negotiating with other contract manufacturers so as to reduce reliance on WuXi AppTec.Let’s see the situation of new orders in following quarters.
  • WuXi AppTec’s performance recovery is closely related to the pace of Fed’s interest rate cuts. From the perspective of growth outlook/macro environment/geopolitical conflicts, WuXi AppTec is still in “dangerous period”.

Dr. Reddy’s Laboratories (DRRD IN): Q4 Result- Sequentially Weak Quarter; Time to Book Profit

By Tina Banerjee

  • Dr. Reddy’s Laboratories (DRRD IN) reported 13% revenue growth to INR71.1B in Q4FY24. EBITDA climbed 15% to INR18.7B, while net profit zoomed 36% to INR13.1B.
  • North America revenue grew 29% YoY to INR32.6B, driven by increase in volumes of base business, contribution from new launches, integration of Mayne portfolio, partly offset by price erosion.
  • After adjusting for brand divestment, revenue from India increased 11% YoY. Gross margin improved 140bps YoY and 10bps QoQ to 58.6%, due to better product mix and cost savings.

Oryzon Genomics – Doubling down on clinical activity in 2024

By Edison Investment Research

Oryzon’s Q124 results emphasised the company’s focus on advancing and expanding its CNS and oncology pipelines, driven by its core assets, vafidemstat and iadademstat. Operating performance was in line, with the lower opex (37% y-o-y decline to €3.2m) driven by reduced R&D spending following completion of the Phase IIb PORTICO trial. Notwithstanding the mixed PORTICO results in borderline personality disorder (BPD), we expect clinical activity to pick up in the coming months, with the initiation of the iadademstat combination studies in first-line AML (Phase Ib) and SCLC (Phase Ib/II) in Q224, and the planned end of Phase II (EoP2) meeting with the FDA in BPD. We also expect interim readouts from the Phase Ib FRIDA study in advanced AML (to be presented at the European Hematology Association conference in June this year). We keep our assumptions broadly unchanged and incorporate the latest net debt figure (€3.7m at end-Q124) in our estimates. Our valuation adjusts to €12.1/share.


AbbVie Inc.: Acquisition of Landos Biopharma to Enhance Autoimmune Disease Treatments & Other Major Developments

By Baptista Research

  • Leading pharmaceutical company AbbVie Inc. has outperformed expectations in its first quarter 2024 results.
  • The financial results and current business outlook reflect the strength and momentum of AbbVie’s diversified pharmaceutical portfolio, which is projected to have long-term growth prospects.
  • The company reported adjusted earnings per share of $2.31 and total net revenues of $12.3 billion, exceeding expectations by $400 million.

XFOR: Data from Phase 2 CN Trial Expected in June 2024

By Zacks Small Cap Research

  • On May 7, 2024, X4 Pharmaceuticals, Inc. (XFOR) announced financial results for the first quarter of 2024.
  • The company will be hosting an investor event in June 2024 to present interim results from the ongoing Phase 2 trial of mavorixafor in chronic neutropenia (CN).
  • The company has initiated the launch of XOLREMDI (mavorixafor) for use in patients 12 years of age and older with WHIM syndrome.

Elanco Animal Hlth Inc (ELAN) – Wednesday, Feb 7, 2024

By Value Investors Club

  • Elanco Animal Health Inc is a leading global provider of pharmaceutical products for Companion Animals and Farm Animals
  • Stock has declined around 50% since early 2020 due to challenges such as the Covid pandemic and disappointing guidance for FY 2022
  • Activist engagement from Sachem Head and a stock price trading at a wide discount to peers make Elanco an intriguing investment opportunity for those willing to weather industry turbulence

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


HCA Healthcare: How Long Is The Continued Strength In Demand for Healthcare Services Expected To Last? – Major Drivers

By Baptista Research

  • HCA Healthcare, one of the largest U.S. health systems, has shown robust quarterly results backed by sustained fundamentals in their business.
  • The momentum primarily results from broad-based volume growth, improved payer mix, and healthy operating margins.
  • While HCA Healthcare generally presents a promising outlook for the rest of the year, the management underscores uncertainties that diverse risks may pose.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Perpetual Ltd, Greentown China, Pioneer Credit, Aon , SK Finance Limited and more

By | Daily Briefs, Financials

In today’s briefing:

  • Perpetual (PPT AU): Shareholders Divided Over Carve Out
  • Morning Views Asia: Adaro Energy, Greentown China, Vedanta Resources
  • Pioneer Credit Ltd – Expected investment guidance upgrade
  • Aon plc: What Will Be The Impact Of The Acceleration of 3×3 Plan On Its 2024 & 2025 Revenues? – Major Drivers
  • SK Finance Pre-IPO Tearsheet


Perpetual (PPT AU): Shareholders Divided Over Carve Out

By David Blennerhassett

  • Back in December last year, Aussie-listed equities manager Perpetual Ltd (PPT AU) rejected Washington H. Soul Pattinson (SOL AU)‘s $3bn all-scrip non-binding indicative proposal. 
  • Yet Soul Patt’s proposal was in sync with Perpetual’s previously flagged intentions to explore a potential separation of its corporate trust and wealth management businesses, from its asset management business.
  • Perpetual has now entered a Scheme, to carve out the corporate trust and wealth management businesses to KKR for A$2.175bn. A lack of clarity on net proceeds saw shares rollover.

Morning Views Asia: Adaro Energy, Greentown China, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Pioneer Credit Ltd – Expected investment guidance upgrade

By Research as a Service (RaaS)

  • Pioneer Credit Limited (ASX:PNC) is one of the leading acquirers and managers of impaired credit in Australia and has gained its status by maintaining positive customer engagement, an unblemished compliance record with ASIC, and strong relationships with Australia’s largest bank and non-bank lenders.
  • PNC purchases debt from numerous Australian vendor partners (18 different vendors in the past 12 months) with long-term partnership purchasing arrangements in place with Commonwealth Bank of Australia (ASX:CBA).
  • Pioneer’s success in purchasing large debt portfolios at attractive IRRs since October highlights the strong position the company occupies in the marketplace, now enhanced by the recent purchases on attractive IRRs.

Aon plc: What Will Be The Impact Of The Acceleration of 3×3 Plan On Its 2024 & 2025 Revenues? – Major Drivers

By Baptista Research

  • Aon Plc has delivered a strong start to the year, reporting 5% overall organic revenue growth, a 100 basis point margin expansion, and 9% EPS growth.
  • He highlighted that the company managed to deliver solid results during the quarter despite commercial risk pressures and a slow rebound in M&A and IPO activity.
  • Regardless, Aon Plc was able to close its acquisition of NFP, which is said to strengthen its position in the fast-growing $31 billion North American middle market.

SK Finance Pre-IPO Tearsheet

By Clarence Chu

  • SK Finance Limited (0893736D IN) is looking to raise US$260m in its upcoming India IPO. The bookrunners on the deal are Kotak, Jefferies, Motilal Oswal, and Nomura.
  • SK Finance is a non-deposit non-banking finance company middle layer (NBFC ML) operating in two main verticals, vehicle financing and financing for micro, small and medium enterprises (MSMEs).
  • As per the CRISIL report in the DRHP, the firm was the fastest growing player in the vehicle financing and MSME financing segments based on AUM growth over FY21-23.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Alibaba Group Holding , Swiggy, IMAX China Holding, Ferrari N.V., Shoppers Stop, ADT , Columbia Sportswear Co, Harley Davidson, Colgate Palmolive Co, Mohawk Industries and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Alibaba (BABA US): Margin Pressure Overstated
  • Swiggy Pre-IPO Early Look – Innovation Leader, Profitability Laggard
  • Flagging a potentially interesting situation: IMAX China (HKG: 1970)
  • Ferrari Q1 FY24: Another Beat, Conservative Guidance And High-Quality Growth
  • Earnings Playbook | Shoppers Stop (SHOP IN) | Target of Quadrupling Network
  • ADT Inc.: A Streamlined Business Model Driving Growth! – Major Drivers
  • Columbia Sportswear Company: What Is The Expected Impact Of The Recovery Of U.S. Consumer Activity> – Major Drivers
  • Harley-Davidson Inc.: Investment in LiveWire segment & The Impact On revenue! – Major Drivers
  • Colgate-Palmolive Company: What Is Its New Consumer Behavior Management Strategy? – Major Drivers
  • Mohawk Industries Inc.: Is Expectation of Consumer Confidence and Housing Market Improvement Realistic? – Major Drivers


Alibaba (BABA US): Margin Pressure Overstated

By Eric Chen

  • We feel consensus overstates margin pressure for Alibaba’s March quarter results. We expect its group adjusted EBITA to deliver single-digit growth vs. investors’ concern about earnings retreat.
  • March quarter should mark start of an earnings recovery cycle in our view, as improving China macro and well-executed business revamp plan put Alibaba back on growth track.
  • This also means an end to its multiple contraction which lasted for five quarters. We see 50% upside on double-digit earnings growth and multiple expansion over next 12 months.

Swiggy Pre-IPO Early Look – Innovation Leader, Profitability Laggard

By Sumeet Singh

  • Swiggy aims to raise US$1.25bn in its upcoming India IPO. The company has filed confidentially for its IPO, which is likely to be launched towards the end of the year.
  • Swiggy, along with Zomato, operates a duopoly that has come to dominate the food delivery market in India. In 1H24, Swiggy serviced over 274,000 restaurants via its 370,000 delivery partners.
  • In this note, we will take an early look at the company based on the publicly available financials. 

Flagging a potentially interesting situation: IMAX China (HKG: 1970)

By Acid Investments

  • IMAX Corp, listed on the NYSE, is a 71% shareholder of IMAX China, a HKEX listed subsidiary – in charge of the release of IMAX films in Greater China.

  • IMAX HK is rather illiquid – 7.15 HK is a mere $0.93 USD – with no investor presentations, no earnings calls – again, as is common with ideas in this blog, we are dealing with a company that is more or less “unownable” for most, flies under the radar, and therefore sports a, for a lack of a better word, shite valuation.

  • Whilst IMAX Corp, the parent company, trades at ~8x EBITDA, the “backwater” subsidiary IMAX HK, trades at a mere ~5x EBITDA, despite margins being more than 10 pts higher.

Ferrari Q1 FY24: Another Beat, Conservative Guidance And High-Quality Growth

By Sameer Taneja

  • Ferrari N.V. (RACE US) reported yet another high-quality quarter with 11%/18% YoY revenue/net profit growth on a flat YoY(%) volume quarter driven by mix improvement.
  • Although there seems to be earnings upside, and the street was literally searching for it in the concall, management stuck to their 6.5%/9% revenue/net profit growth guidance for FY24.
  • Trading at 50x FY24, the stock seems expensive, but the strong branding and order book implies very visible earnings growth into the future.  

Earnings Playbook | Shoppers Stop (SHOP IN) | Target of Quadrupling Network

By Pranav Bhavsar


ADT Inc.: A Streamlined Business Model Driving Growth! – Major Drivers

By Baptista Research

  • The first quarter 2024 results of ADT Inc. highlight the company’s positive growth and future investment opportunities.
  • The company continues to focus on its consumer-oriented core security and smart home business, serving a vast market.
  • Being an industry leader, ADT benefits from its trusted brand, national footprints, and the ability to tap stable and predictable cash flows to service and reduce its debt obligations.

Columbia Sportswear Company: What Is The Expected Impact Of The Recovery Of U.S. Consumer Activity> – Major Drivers

By Baptista Research

  • Columbia Sportswear demonstrated solid management of its inventory and its operational costs.
  • The company reported a 37% year-over-year reduction in inventory and the implementation of an inventory reduction plan that has reaped substantial benefits.
  • Columbia Sportswear’s strong balance sheet supports its maneuvers to tackle the impact of coronavirus-induced disruptions and realign inventory.

Harley-Davidson Inc.: Investment in LiveWire segment & The Impact On revenue! – Major Drivers

By Baptista Research

  • Harley-Davidson had a mixed performance in the recent result.
  • The company delivered in line with expectations, reporting a 6% growth in North America, the most important region.
  • However, this growth was offset by soft performances in Europe and the Asia Pacific primarily due to regional macroeconomic conditions.

Colgate-Palmolive Company: What Is Its New Consumer Behavior Management Strategy? – Major Drivers

By Baptista Research

  • Colgate-Palmolive’s Q1 2024 earnings reveal a positive start to the year, with balanced top-line growth and consistent earnings per share growth.
  • The company recorded organic sales growth across all four of its categories and all six of its divisions, as well as volume and pricing growth on a total company basis.
  • This balanced growth enabled a 6% net sales growth, despite a nearly 4% headwind from foreign exchange.

Mohawk Industries Inc.: Is Expectation of Consumer Confidence and Housing Market Improvement Realistic? – Major Drivers

By Baptista Research

  • Mohawk Industries’ Q1 2024 earnings call detailed a challenging period marked by economic headwinds and mixed performance.
  • The company’s net sales for the first quarter were $2.7 billion, a drop of 4.5% compared to the previous year.
  • However, the adjusted earnings per share increased by 6% year-over-year to $1.86.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Namoi Cotton Co Operative, Pureprofile Ltd, Recce Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Namoi Cotton (NAM AU): Bloom Times As Louis Dreyfus & Olam Agri Tangle
  • Pureprofile Ltd – EBITDA margin guidance upgraded
  • Recce Pharmaceuticals – Advances on several fronts


Namoi Cotton (NAM AU): Bloom Times As Louis Dreyfus & Olam Agri Tangle

By David Blennerhassett

  • Singapore’s Olam Agri and global commodity merchant Louis Dreyfus Company (LDC) are duking it out for Namoi Cotton Co Operative (NAM AU), Australia’s largest cotton producer.
  • After both initially lobbed competing Schemes, both have now tabled off-market Offers – A$0.67/share from LDC, A$0.66/share from Olam – each contingent on a 50.1% acceptance hurdle, FIRB, and ACCC. 
  • LDC, currently holding 17%, announced it will reject Olam Agri’s Offer. Top shareholder Samuel Terry Asset Management, with 24.5%, is expected to support the winning (or superior) bid.  

Pureprofile Ltd – EBITDA margin guidance upgraded

By Research as a Service (RaaS)

  • Pureprofile Ltd (ASX:PPL) is a data analytics and consumer insights company underpinned by proprietary technology, servicing business decision makers in brands and media companies as well as market researchers.
  • Pureprofile reported a 6% increase in Q3 FY24 revenue to $10.9m and a 49% decline in Q3 EBITDA to $0.5m versus the previous corresponding period (pcp).
  • Q3 is seasonally the weakest quarter for PPL and EBITDA was affected, in part, by the change in executive remuneration policy to cash-based payments.

Recce Pharmaceuticals – Advances on several fronts

By Edison Investment Research

Recce Pharmaceuticals has reported several encouraging developments in recent weeks for its lead development compound RECCE® 327 (R327). The intravenous (IV) R327 formulation is advancing to a higher dose level (4,000mg) in its ongoing Phase I/II rapid infusion study and the company is progressing in its plan to submit a US Investigational New Drug (IND) application to commence a US Phase II complicated urinary tract infection (cUTI) study before end-CY24. Recce is also planning to start an Indonesian Phase III registrational study in Q3 CY24, which we anticipate could lead to initial commercialisation in South-East Asia in H2 CY26. We have made minor adjustments to our valuation and now obtain a risk-adjusted net present value (rNPV) of A$661.3m (or A$3.27/share), versus A$644.4m previously.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SeAH Steel Holdings and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Quiddity Leaderboard KOSPI 200 Jun 24: One Last-Minute Change to Rankings


Quiddity Leaderboard KOSPI 200 Jun 24: One Last-Minute Change to Rankings

By Travis Lundy

  • KOSPI 200 is a Korean blue-chip index that tracks the 200 largest and most-liquid names listed in the KOSPI section of the Korea Exchange (KRX).
  • The reference period for the June 2024 index rebal event ended recently. In this insight, we take a look at our final expected ADDs/DELs.
  • There has been one change to our list of expected ADDs presented in my last insight (link).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Singapore Airlines and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Singapore Airlines – 4Q Likely to Extend the Theme of Earnings Normalization as FY25 Comes into View


Singapore Airlines – 4Q Likely to Extend the Theme of Earnings Normalization as FY25 Comes into View

By Neil Glynn

  • We expect Singapore Airlines to report a disappointing 4Q24 on 15 May, as earnings normalisation continues.
  • Inflationary pressure is a key theme at SIA, with it suffering one of the highest levels of inflation in the APAC region.
  • Our forecasts for FY25, which suggest further earnings normalisation, are c.20% below consensus at the operating level.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: S&P 500 INDEX, Bitcoin Pro, Titan International , Gaia, Gevo, Leef Brands , Adeia, Zimvie , Cheniere Energy, East West Bancorp and more

By | Daily Briefs, United States

In today’s briefing:

  • Major Risk-On Developments; Bullish Outlook Intact; Downgrading Health Care $XLV to Underweight
  • Bitcoin Battles ETF Outflows
  • TWI: Titan announces 1st quarter 2024 results and updates the investor community on industry conditions.
  • Gaia, Inc. – Solid Top-Line Momentum Continues in 1Q24
  • Gevo, Inc. – 1Q24 Results: Share Repurchase Underway
  • LEEF Brands, Inc. – Announces Debt Restructuring, Settlement for Equity, and Equity Offering
  • ADEA: Setting Course for New Licensees
  • Zimvie Inc (ZIMV) – Tuesday, Feb 6, 2024
  • Cheniere Energy Inc (LNG) – Tuesday, Feb 6, 2024
  • East West Bancorp Inc (EWBC) – Tuesday, Feb 6, 2024


Major Risk-On Developments; Bullish Outlook Intact; Downgrading Health Care $XLV to Underweight

By Joe Jasper

  • Over the past two weeks we’ve discussed the possibility that further downside was limited (4/23/24 Compass) and mounting evidence that suggests the pullback lows may be in (4/30/24 Compass).
  • Major risk-on developments for the broad equity market have continued to roll in over the past week, which we discuss below.
  • We continue to believe the lows are in, and we see the pullback to the 100-day MA on the S&P 500 as healthy/normal within the ongoing bull market.

Bitcoin Battles ETF Outflows

By Delphi Digital

  • BTC Spot ETFs Unlock Institutional Capital: Explore the impact of Bitcoin Spot ETFs, opening doors to institutional investment.
  • Market Insights Drive BTC Performance: Understand BTC’s resilience and trajectory through market dynamics and performance analysis.
  • Token Unlocks Shape Market Dynamics: Stay ahead of market shifts by monitoring upcoming token unlocks.

TWI: Titan announces 1st quarter 2024 results and updates the investor community on industry conditions.

By Zacks Small Cap Research

  • Titan International is a global manufacturer of off-the-road tires, wheels and undercarriages.
  • The company serves the agricultural, earthmoving / construction, and consumer markets.
  • Recent strategic actions have created higher margins in recent years and brought the leverage ratio down to 2.0x.

Gaia, Inc. – Solid Top-Line Momentum Continues in 1Q24

By Water Tower Research

  • Gaia reported strong 1Q24 results, with revenue of $21.7 million (up 11%), 33,000 net member additions for a total membership count of 839,000 (all-time high), and strong operating cash flow of $5.9 million.
  • International revenue growth was particularly strong at 20.4%, compared with respectable US growth of 3.7%.
  • Member acquisition costs decreased 10%, partly as a result of a focus on direct-to-paid marketing campaigns, whereby free trial periods are replaced by special incentives to lock in longer-term membership commitments at attractive rates. This also fueled healthy deferred revenue growth of $2.0 million during the quarter.

Gevo, Inc. – 1Q24 Results: Share Repurchase Underway

By Water Tower Research

  • Gevo has begun repurchasing shares under the company’s previously announced program.
  • The company has so far repurchased 5.5 million shares for $3.7 million, leaving $21.3 million available for repurchases.
  • Gevo revised spending on its Net-Zero 1 plant project. 

LEEF Brands, Inc. – Announces Debt Restructuring, Settlement for Equity, and Equity Offering

By Water Tower Research

  • LEEF Brands (CSE: LEEF, OTCQX: LEEEF) is a scaled, vertically integrated operator in California.
  • It holds the largest cultivation permit in Santa Barbara County, owns LEEF Labs, one of the state’s largest manufacturing companies, and has The Leaf dispensary in Palm Springs.
  • The company recently successfully restructured its debt. 

ADEA: Setting Course for New Licensees

By Hamed Khorsand

  • ADEA signed ten license agreements and reduced debt by approximately $40 million in the first quarter. ADEA has yet to announce a new major OTT license aside from Paramount renewing.
  • The investment case for owning ADEA’s stock has centered on the Company’s ability to sign more license agreements
  • ADEA remains on pace to generate $150 million of free cash flow to help reduce the Company’s debt balance further.

Zimvie Inc (ZIMV) – Tuesday, Feb 6, 2024

By Value Investors Club

  • ZimVie Inc. historically focused on dental and spine industries since spinning out from Zimmer Biomet in 2022
  • Company faced challenges with large debt burden and declining spine business, leading to discounted valuation
  • Recent sale of spine business to HIG Capital for $375 million expected to eliminate overhangs, simplify valuation, and position company for stronger future performance

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Cheniere Energy Inc (LNG) – Tuesday, Feb 6, 2024

By Value Investors Club

  • Cheniere Energy (LNG) expected to have significant performance catalyst in 2024 with 4Q23 EPS print on 2/22/24
  • Sell side has adjusted numbers for 2024 despite recent underperformance
  • Anticipated conservative guidance for 2024 sets up positive surprise for investors due to focus on “tariff” type earnings and long-term contracts in place

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


East West Bancorp Inc (EWBC) – Tuesday, Feb 6, 2024

By Value Investors Club

Key points

  • Short shares of EWBC, a medium-sized regional bank serving the Chinese/Asian expat community
  • Trading at 1.5x price/TBV with compression in NIM and increased deposit costs
  • Concerns about CRE exposure, uninsured deposits, investments in China/HK, and creditworthiness due to uniquely correlated customer base and soft guidance from management

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Greentown China and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Morning Views Asia: Adaro Energy, Greentown China, Vedanta Resources


Morning Views Asia: Adaro Energy, Greentown China, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars